Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Preferred Stock	Common Stock	Additional Paid-in Capital (Deficit)	Accumulated Comprehensive Loss	Accumulated Deficit	Total
Balance beginning at Dec. 31, 2013		$ 4,670	$ 12,396,356	$ 3,649	$ (12,738,023)	$ (333,348)
Balance beginning, Shares at Dec. 31, 2013		462,355
Sale of common stock, net of issuance costs		$ 396	663,314			$ 663,710
Sale of common stock, net of issuance costs, Shares		39,235
Exchange of Trunity Holdings, Inc. preferred stock for True Nature Holding, Inc. common stock
Debt beneficial conversion feature for shares and warrants			189,687			$ 189,687
Common stock issued upon conversion of note payable, net of issuance costs		$ 50	94,940			$ 94,990
Common stock issued upon conversion of note payable, net of issuance costs, Shares		5,000
Common stock issued upon conversion of debenture prior to Spin-Out
Discount related to issuance of debt with warrants and allocated fair value to beneficial conversion feature prior to Spin-Out
Stock compensation expense - discontinued operations
Gain on extinguishment of debt - discontinued operations
Foreign currency translation gain - discontinued operations
Common stock issued for satisfaction of payables
Common stock issued to Spin-Out Company, Trunity Inc.
Shares issued and adjustments related to reverse split
Shares issued for services		$ 350	69,650			$ 70,000
Shares issued for services, Shares		34,654
Warrants issued for services			20,752			20,752
Common stock issued for convertible note payable		$ 14	24,736			$ 24,750
Common stock issued for convertible note payable, Shares		1,361
Spin-out adjustment
Stock compensation period costs			450,736			$ 450,736
Loss on debt extinguishment			$ 310,096			310,096
Foreign currency translation gain				$ 14,325		14,325
Net loss					$ (3,770,144)	(3,770,144)
Balance ending at Dec. 31, 2014		$ 5,480	$ 14,220,267	$ 17,974	$ (16,508,167)	$ (2,264,446)
Balance ending, Shares at Dec. 31, 2014		542,605				542,605
Issuance of Trunity Holdings, Inc. preferred stock for acquisition of Newco4pharmacy, LLC			106,900			$ 106,900
Issuance of Trunity Holdings, Inc. preferred stock for acquisition of Newco4pharmacy, LLC, Shares	1,000
Exchange of Trunity Holdings, Inc. preferred stock for True Nature Holding, Inc. common stock		$ 100,000	(100,000)
Exchange of Trunity Holdings, Inc. preferred stock for True Nature Holding, Inc. common stock, Shares	(1,000)	10,000,000
Common stock issued upon conversion of debenture prior to Spin-Out		$ 883	141,631			$ 142,514
Common stock issued upon conversion of debenture prior to Spin-Out, Shares		87,383
Discount related to issuance of debt with warrants and allocated fair value to beneficial conversion feature prior to Spin-Out			274,122			274,122
Discount related to issuance of debt with warrants and allocated fair value to beneficial conversion feature prior to Spin-Out, Shares
Stock compensation expense - discontinued operations			151,708			151,708
Gain on extinguishment of debt - discontinued operations			$ (1,867,428)			(1,867,428)
Foreign currency translation gain - discontinued operations				$ 24,815		$ 24,815
Common stock issued for conversion of debt		$ 7,421	$ (7,421)
Common stock issued for conversion of debt, Shares		742,098
Common stock issued for satisfaction of payables		$ 1,893	(1,893)
Common stock issued for satisfaction of payables, Shares		189,305
Common stock issued to Spin-Out Company, Trunity Inc.		$ 2,033	(2,033)
Common stock issued to Spin-Out Company, Trunity Inc., Shares		203,293
Shares issued and adjustments related to reverse split		$ (60)	$ 60
Shares issued and adjustments related to reverse split, Shares		316
Net loss from discontinued operations, net of tax					$ (337,362)	$ (337,362)
Spin-out adjustment			$ (12,915,913)	$ (42,789)	$ 16,269,926	3,311,224
Stock compensation period costs			$ 3,917			3,917
Net loss					$ (65,652)	(403,014)
Balance ending at Dec. 31, 2015		$ 117,650	$ 3,917		$ (641,255)	$ (519,688)
Balance ending, Shares at Dec. 31, 2015		11,765,000				11,765,000